Larvol Cliniclarvol.hashnode.devยทAug 16, 2024Sequential Sacituzumab Govitecan and Talazoparib in Metastatic Triple-Negative Breast CancerAbstract Purpose: The antibody-drug conjugate (ADC) sacituzumab govitecan (SG) comprises the topoisomerase 1 (TOP1) inhibitor (TOP1i) SN-38, coupled to a monoclonal antibody targeting trophoblast cell surface antigen 2 (TROP-2). Poly(ADP-ribose) poly...TumorAdd a thoughtful commentNo comments yetBe the first to start the conversation.
